提问
问诊
发现
计算
注册
注册
登录
登录
发现
GLP-1 Receptor Agonists Reduce Cardiovascular, Kidney, and Mortality Risks in Patients with Systemic Lupus Erythematosus and Type 2 Diabetes - Vera Health News